8th INTEREST

Workshop 1: Paediatric HIV Infection in the context of the elimination of new HIV Infections in Children and child survival
Workshop 2: Implementation Science
   
SESSION 1: HIV DRUG RESISTANCE IN AFRICA
Transmitted and acquired HIV drug resistance in Africa
Dr. Raph Hamers
Paediatric HIV drug resistance in African settings
Dr. Cissy Kityo
Affordable HIV drug resistance tests – options for Africa
Dr. Sue Aitken
New WHO guidelines on HIV drug resistance monitoring and surveillance
Dr. Silvia Bertagnolio
SATELLITE SYMPOSIUM: Growning pains: Developing adequate strategies for HIV care in children and adolescents
Janssen Pharmaceutica NV
Review of recent changes in WHO and national paediatric care guidelines
Dr. Chewe Luo
Current challenges of paediatric HIV care – Experiences in Sub-Saharan Africa
Dr. Elizabeth Obimbo
Second and third line paediatric ART strategies
Dr. Marape Marape
SATELLITE SYMPOSIUM: Optimizing HIV management in Resource-limited Settings
AbbVie
Men infected with HIV: Are we doing enough?
Dr. Francesca Conradie
Managing HIV in children: Best practices
Dr. Mo Archary
Viral load monitoring in RLS: Challenges and successes
Dr. Albert Mwango
OPENING SESSION
HIV in Zambia
Dr. Albert Mwango
Key affected populations
Dr. Helen Rees
HIV cure research: State-of-the-art
Dr. Robert Schooley
SESSION 2-3: HIV PREVENTION
Combination HIV prevention (Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART)
Dr. Helen Ayles
PrEP, State-of-the-art and roll-out
Dr. Catherine Hankins
Update on circumcision (methods and roll-out)
Dr. Kasonde Bowa
HIV vaccine update
Dr. Merlin Robb
SATELLITE SYMPOSIUM: Tenofovir (TDF) and TRUVADA (TVD): A look back and current updates
Gilead Sciences
TDF containing ART: Efficacy and Safety
Dr. Lloyd Mulenga
TVD: Differentiation of FTC and 3TC
Dr. François Venter
SESSION 4: TREATMENT AS PREVENTION (TasP) - Ongoing studies, challenges and opportunities
Roundtable Discussion
Africa Center Project (Kwazulu Natal)
Dr. Frank Tanser
ANRS study
Dr. Frank Tanser
Swaziland MaxART project
Dr. Velephi Nhlengetfwa Okello
Community perspective
Dr. Moono Nyambe
SESSION 5: Symposium on hepatitis virus infections (HBV, HCV)
Epidemiology of hepatitis virus infections in Africa
Dr. Harr Freeya Njai
Screening & diagnosis of hepatitis virus infections
Dr. Jean-Michel Pawlotsky
Screening & diagnosis of hepatitis B infection in Zambia
Dr. Michael Vinikoor
Prevention and treatment of HBV infections
Dr. Monique Andersson
Treatment of HCV infections: past, present, and future
Dr. Jean-Michel Pawlotsky
SESSION 6-7: Plenary Session
HIV treatment update: New drugs/new studies
Dr. François Venter
Broadly neutralizing antibodies in the prevention and treatment of HIV
Dr. Coleen Cunningham
Hot issues in TB: Treatment of latent TB; New drugs and diagnostics
Dr. Constance Benson
HIV neurology
Dr. Victor Valcour
How to improve adherence to medication
Dr. Jayne Byakika-Tusiime
SESSION 8: New WHO Guidelines - the African perspective - how to implement?
Roundtable Discussion
WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Introduction
Dr. Joep Lange
Infant and Child HIV testing in Zambia: Lessons Learnt 
Dr. Namwinga Chintu
SESSION 9: Oral abstracts
The continuum of HIV Care in Zimbabwe
Dr. Peter Kilmarx
The relationship between adherence to clinic appointments and year-one mortality for HIV infected patients at a Referral Hospital in Western Kenya
Dr. Kimea Muthusi
ARV uptake and seroincidence by ARV status among HIV discordant couples in Copperbelt province, Zambia
Dr. William Kilembe
Short-term safety profile of Atazanavir/ritonavirbased second-line therapy among HIV-infected adults in Zambia
Dr. Mpande Mukumbwa-Mwenechanya
Clinical implementation of HIV-1 resistance testing on dried blood spots in a rural South African Setting
Dr. Lucas Hermans
Incremental costs of implementing automated ELISA systems for early Cryptococcal antigenaemia detection at a high-volume public-sector laboratory inSouth Africa
Dr. Naseem Cassim
Cost-per-HIV infection averted by couples' HIV counseling and testing (CVCT) in government clinics in Copperbelt, Zambia
Dr. Inambao
Overlap of high risk behaviors in men injecting drugs among high risk men for HIV in Ghana
Dr. Samuel Gathuya
One is not enough – using non-traditional approaches to reach msm with hiv prevention, testing and counseling and care
Dr. Nana Fosua Clement
SESSION 10: Plenary Session
Tackling HIV and NCD’s
Dr. Moses Kamya
TB (The Zambia AIDS Related Tuberculosis (ZAMBART) Project
Dr. Monde Muyoyeta
SESSION 11: Oral abstracts
Estimating the association between duration of HAART before delivery and low infant birthweight using data from the Zambian Electronic Perinatal Records System
Dr. Nancy Hancock
Using a regression discontinuity (RD) approach to investigate the effect of combination antiretroviral therapy (cART) in pregnancy on birth outcomes in Zambia
Dr. Arianna Zanolini
Characteristics and outcomes of HIV-infected pregnant women accepting combination ART for PMTCT in Zambia
Dr. Cherry Liu
Safety and efficacy of darunavir/ritonavir in treatment-experienced pediatric patients aged 3 to <6 Years: Week 48 analysis of the ARIEL trial
Dr. Avy Violari
Roundtable Discussion: Hormonal contraception and HIV
Progestin injectable contraceptive – The history of the debate
Dr. Helen Rees
From evidence to policy; the MEC process
Dr. Mike Mbizvo
Examining all the evidence
Dr. Chelsea Polis
The proposed ECHO study
Dr. Nelly Rwamba Mugo